Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in Relapsed/Refractory PCNSL or PTL
NCT02857426Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2016
- Primary completion
- Jun 2019
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 2 trial of nivolumab in primary central nervous system lymphoma (PCNSL), primary testicular lymphoma (PTL), sponsored by Bristol Myers Squibb. Started Oct 2016; status: completed.
02
Drugs
03
Conditions
primary central nervous system lymphoma (PCNSL)primary testicular lymphoma (PTL)
Beyond the preview
Go deeper on NCT02857426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02857426.